Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC

Osbourne Quaye, Precious Cramer, Mark Ofosuhene, Laud K.N. Okine, Alexander K. Nyarko

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Extracts of Desmodium adscendens (Sw) DC are used for the treatment of various diseases but limited toxicological evaluations have been done on the medicinal plant. This study investigates toxicity effects of the leave extract of D adscendens, and the possibility of drug-drug interaction of the plant extract when co-administered with other drugs. Oral administrations of leaf extract of D adscendens to white Wistar rats in an acute toxicity studies allowed the estimation of an LD50 (median lethal dose) value of 1122 mg/kg body weight. In a subchronic toxicity studies, the plant extract caused a decrease in zoxazolamine paralysis time and prevented thiopentone from causing sleep in test animals compared to controls. Overall, the results are consistent with the plant extract being safe at the doses administered in humans. However, the induction of the CYP enzymes is an indication of a possible drug interaction when the plant extract is co-administered with other drugs.

Original languageEnglish
Pages (from-to)753-759
Number of pages7
JournalJournal of Evidence-Based Complementary and Alternative Medicine
Volume22
Issue number4
DOIs
Publication statusPublished - 1 Oct 2017

Keywords

  • Desmodium adscendens (Sw) DC
  • acute toxicity
  • cytochrome P450 xenobiotic-metabolizing enzymes
  • drug metabolism
  • subchronic toxicity

Fingerprint

Dive into the research topics of 'Acute and Subchronic Toxicity Studies of Aqueous Extract of Desmodium adscendens (Sw) DC'. Together they form a unique fingerprint.

Cite this